These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 13879288)

  • 1. Changes in spider webs brought about by mescaline, psilocybin and an increase in body weight.
    CHRISTIANSEN A; BAUM R; WITT PN
    J Pharmacol Exp Ther; 1962 Apr; 136():31-7. PubMed ID: 13879288
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of psilocin with psilocybin, mescaline and LSD-25.
    WOLBACH AB; MINER EJ; ISBELL H
    Psychopharmacologia; 1962; 3():219-23. PubMed ID: 14007905
    [No Abstract]   [Full Text] [Related]  

  • 3. THE HALLUCINOGENIC DRUGS.
    BARRON F; JARVIK ME; BUNNELL S
    Sci Am; 1964 Apr; 210():29-37. PubMed ID: 14143391
    [No Abstract]   [Full Text] [Related]  

  • 4. PSYCHOTOMIMETICS--A NEUROPHARMACOLOGICAL STUDY.
    CURTIS DR
    Proc Aust Assoc Neurol; 1963 May; 72():43-5. PubMed ID: 14158382
    [No Abstract]   [Full Text] [Related]  

  • 5. Mescaline, lysergic acid diethylamide and psilocybin comparison of clinical syndromes, effects on color perception and biochemical measures.
    HOLLISTER LE; HARTMAN AM
    Compr Psychiatry; 1962 Aug; 3():235-42. PubMed ID: 13908449
    [No Abstract]   [Full Text] [Related]  

  • 6. [Teonanacatl and psilocybin].
    CERLETTI A
    Dtsch Med Wochenschr; 1959 Dec; 84():2317-21. PubMed ID: 13808846
    [No Abstract]   [Full Text] [Related]  

  • 7. [Psilocybin, a new hallucinogen].
    ROUBICEK J; DRVOTA S
    Cesk Psychiatr; 1960 Feb; 56():44-55. PubMed ID: 14439519
    [No Abstract]   [Full Text] [Related]  

  • 8. EFFECT OF CENTRALLY-ACTING DRUGS ON MOBILIZATION OF FREE FATTY ACIDS.
    HOLLISTER LE
    Arch Int Pharmacodyn Ther; 1964 Jun; 149():362-5. PubMed ID: 14191070
    [No Abstract]   [Full Text] [Related]  

  • 9. [The place of psilocybin among other psychotropic substances].
    RUEMMELE W
    Schweiz Arch Neurol Neurochir Psychiatr; 1959; 84():348-52. PubMed ID: 14440055
    [No Abstract]   [Full Text] [Related]  

  • 10. [Psychopsychic correlations under the effect of psycholytics (LSD, psilocybin and similar drugs)].
    HOLFELD H
    Med Exp Int J Exp Med; 1961; 5():209-14. PubMed ID: 13908338
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of psilocybin on the excitability of the nerve centers].
    CHAUCHARD P; MAZOUE H
    C R Seances Soc Biol Fil; 1961; 155():71-2. PubMed ID: 24545494
    [No Abstract]   [Full Text] [Related]  

  • 12. Cross tolerance between LSD and psilocybin.
    ISBELL H; WOLBACH AB; WIKLER A; MINER EJ
    Psychopharmacologia; 1961; 2():147-59. PubMed ID: 13717955
    [No Abstract]   [Full Text] [Related]  

  • 13. [RESEARCH CONCERNING THE PHARMACOLOGIC CHARACTERIZATION AND DIFFERENTIATION OF HALLUCINOGENIC DRUGS (INDOLE DERIVATES AND MESCALINE, NALORPHINE, CENTRAL ANTICHOLINERGIC AGENTS, PHENCYCLIDINE)].
    JACOB J; LAFILLE C; LOISEAU G; ECHINARD-GARIN P; BARTHELEMY C
    Encephale; 1964; 53():520-35. PubMed ID: 14222727
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serotonin metabolism in experimental psilocybin psychosis].
    VITEK V; VOJTECHOVSKY M; GROF S
    Act Nerv Super (Praha); 1961 May; 3():213-5. PubMed ID: 13926289
    [No Abstract]   [Full Text] [Related]  

  • 15. [Expressive phenomenology of model psychoses (psilocybin). Comparison with self-description and psychic deficiency of performance].
    HEIMANN H
    Psychiatr Neurol (Basel); 1961 Jan; 141():69-100. PubMed ID: 13712866
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on psilocybin, a hallucinogenic drug from the Mexican mushroom Psilocybe mexicana].
    GNIRSS F
    Schweiz Arch Neurol Neurochir Psychiatr; 1959; 84():346-8. PubMed ID: 13850311
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of psilocybin upon the systemic, pulmonary, and coronary circulation of the intact dog.
    MAXWELL GM; KNEEBONE GM; ELLIOTT RB
    Arch Int Pharmacodyn Ther; 1962 May; 137():108-15. PubMed ID: 14471633
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychotomimetic drugs: biochemistry and pharmacology.
    Brimblecombe RW
    Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on psilocybin and related compounds. I. Communication. Structure/activity relationship of oxyindole-derivatives with regard to their effect on the knee jerk of spinal cats.
    WEIDMANN H; CERLETTI A
    Helv Physiol Pharmacol Acta; 1960; 18():174-82. PubMed ID: 13843476
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hallucinogenic mushrooms and psilocybine].
    DEYSSON G
    Proc Pharm Soc Egypt; 1960 Jan; 15():27-9. PubMed ID: 24546366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.